EUVIMEDEUVIMED entdecken
Crossref

The importance of Immunotherapy in 2013/14 vs. 2022/23 – A survey of the DGHNO Oncology Working Group

Ayla Grages, Jule M. Heil, Jana Kimmeyer, Thomas Hoffmann, Shachi Jenny Sharma, Sami Shabli, Henrike Zech, Christian Betz, Susanne Wiegand, Andreas Dietz, Roman Braun, Gregor Wolf und 24 weitere

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S201

DOI: 10.1055/s-0044-1784650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Ayla Grages und 35 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Since our last survey on systemic oncologic therapy (SOT), PD-1 antibodies were approved for palliative treatment of head and neck squamous cell carcinoma (HNSCC). Several years after this approval, we repeated the survey posing exactly the same questions. Material / Method An online survey (OS) directed at all Otorhinolaryngology departments was conducted in the years 2013/14 (OS1) and 22/23 (OS2) (including Austria and Switzerland in OS1). Seven questions assessing the importance of immunotherapy (IT) were posed. The ordinally scaled answers were analyzed using Chi2 tests (likelihood ratio).

Results

In OS1, 62/204 centers (30.3%) responded and in OS2 51/172 centers (29.6%). The current importance of IT was assessed significantly higher (p

Zitieren

APA

Grages, A., Heil, J. M., Kimmeyer, J., Hoffmann, T., Sharma, S. J., Shabli, S., Zech, H., Betz, C., Wiegand, S., Dietz, A., Braun, R., Wolf, G., Eichhorn, S., Park, J., Evers, T., Tisch, M., Federspil, P. A., Heidemann, J., Hofmann, V. M., …, & Laban, S. (2024). The importance of Immunotherapy in 2013/14 vs. 2022/23 – A survey of the DGHNO Oncology Working Group. Laryngo-Rhino-Otologie, 103(S 02 S 02), S201. https://doi.org/10.1055/s-0044-1784650

Vancouver

Grages A, Heil JM, Kimmeyer J, Hoffmann T, Sharma SJ, Shabli S, et al. The importance of Immunotherapy in 2013/14 vs. 2022/23 – A survey of the DGHNO Oncology Working Group. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S201. doi:10.1055/s-0044-1784650

BibTeX
@article{Grages2024,
  author = {Grages, Ayla and Heil, Jule M. and Kimmeyer, Jana and Hoffmann, Thomas and Sharma, Shachi Jenny and Shabli, Sami and Zech, Henrike and Betz, Christian and Wiegand, Susanne and Dietz, Andreas and Braun, Roman and Wolf, Gregor and Eichhorn, Sabine and Park, Jonas and Evers, Theo and Tisch, Matthias and Federspil, Philippe A. and Heidemann, Jan and Hofmann, Veit M. and Herzog, Michael and Kisser, Ulrich and Abbaspour, Bektasch and Thomas, Jan Peter and Kürten, Cornelius and Lang, Stephan and Warnecke, Athanasia and Lenarz, Thomas and Schapher, Mirco and Traxdorf, Maximilian and Döscher, Johannes and Thedoraki, Marie-Nicole and Wirth, Markus and Wollenberg, Barbara and Klußmann, Jens Peter and Kurzweg, Thiemo and Laban, Simon},
  title = {The importance of Immunotherapy in 2013/14 vs. 2022/23 – A survey of the DGHNO Oncology Working Group},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S201},
  doi = {10.1055/s-0044-1784650}
}
Kostenlos starten →